Renée V. Gardner

Long‐term safety and efficacy of deferasirox (Exjade^®) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease

Elliott Vichinsky, Françoise Bernaudin, Gian Luca Forni et al. · British Journal of Haematology · 2011 · 78 citations · Full text

Improved response of patients refractory to random-donor platelet transfusions by intravenous gamma globulin

Riitta Kekomäki, Gerald J. Elfenbein, Renée V. Gardner et al. · The American Journal of Medicine · 1984 · 50 citations

Random-donor Platelet Transfusions, Thrombosis, Thrombopoiesis +10

Tumor necrosis factor alpha in children with sickle cell disease in stable condition.

Solo Kuvibidila, Renée V. Gardner, David Ode et al. · PubMed · 1997 · 41 citations · Full text

Assessing permanent damage to primitive hematopoietic stem cells after chemotherapy using the competitive repopulation assay

Renée V. Gardner, Charles P. Lerner, Clinton M. Astle · Cancer Chemotherapy and Pharmacology · 1993 · 41 citations

Cell Therapy, Medicine, Stem Cell Mobilization +12

Hematopoietic precursor cell exhaustion is a cause of proliferative defect in primitive hematopoietic stem cells (PHSC) after chemotherapy.

Renée V. Gardner, C M Astle, David Harrison · PubMed · 1997 · 37 citations